19 June 2013
Keywords: merck, kgaa, submits, snda, japan, gonal-f, serono
Article | 03 November 2008
Merck Serono, the pharmaceuticals division of Germany's Merck KGaA, has submitted a supplemental New Drug Application to the Japanese
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 November 2008
10 November 2008
27 October 2008
© 2013 thepharmaletter.com